Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
According to the latest research, the global Cardiac Biomarkers market size was valued at USD XX million in 2022 and is expected to expand at a CAGR of XX% during the forecast period, reaching USD XX million by 2028.
Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally used as an indicator forparticular diseases such as rheumatic and congenital heart diseases and cardiac arrhythmia. Cardiac biomarkers are measurable and quantifiable biological parameters. These are specifically used to check the presence or severity of cardiovascular diseases. Cardiac biomarkers are the substances that are released into blood when heart is damaged. These biomarkers are also used for diagnosing and monitoring diseases such as coronary syndrome or cardiac ischemia. The symptoms of these diseases includes chest pain, shortness of breath and nausea that ultimately leads to heart attack or angina. Cardiac biomarker tests helps to detect presence of coronary syndrome and cardiac ischemia to evaluate its severity and diagnosis.
This report elaborates on the market size, market characteristics, and market growth of the Cardiac Biomarkers industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Cardiac Biomarkers. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Cardiac Biomarkers Market Report Include:
Market Size Estimates: Cardiac Biomarkers market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Cardiac Biomarkers market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Cardiac Biomarkers market
Segment Market Analysis: Cardiac Biomarkers market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Cardiac Biomarkers market situations and prospects in major and top regions and countries
Cardiac Biomarkers Market
Cardiac Biomarkers Industry Chain: Cardiac Biomarkers market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Cardiac Biomarkers Industry News, Policies by regions
Cardiac Biomarkers Industry Porters Five Forces Analysis
Key players in the global Cardiac Biomarkers market are covered in Chapter 2:
Thermo Fisher Scientific Inc.
Randox laboratories Ltd.
Guangzhou Wondfo Biotech Co., Ltd
AgPlus Diagnostics
Alere Inc.
Danaher Corporation
Abbott Laboratories
LSI Medience Corporation
BioLegend
BG Medicine
Bio-Rad Laboratories
Tosoh Corporation
Siemens Healthineers AG
DiaSorin S.p.A.
Advanced ImmunoChemical
bioMérieux SA
Ortho Clinical Diagnostics
Roche Diagnostics Ltd.
In Chapter 6 and Chapter 9, on the basis of types, the Cardiac Biomarkers market from 2018 to 2028 is primarily split into:
Troponin
CK-MB
Natriuretic Peptides - BNP and NT-proBNP
Myoglobin
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Cardiac Biomarkers market from 2018 to 2028 covers:
Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Cardiac Biomarkers market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Cardiac Biomarkers industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Cardiac Biomarkers market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Cardiac Biomarkers industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Cardiac Biomarkers market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Cardiac Biomarkers market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Cardiac Biomarkers market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
2022
Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally used as an indicator forparticular diseases such as rheumatic and congenital heart diseases and cardiac arrhythmia. Cardiac biomarkers are measurable and quantifiable biological parameters. These are specifically used to check the presence or severity of cardiovascular diseases. Cardiac biomarkers are the substances that are released into blood when heart is damaged. These biomarkers are also used for diagnosing and monitoring diseases such as coronary syndrome or cardiac ischemia. The symptoms of these diseases includes chest pain, shortness of breath and nausea that ultimately leads to heart attack or angina. Cardiac biomarker tests helps to detect presence of coronary syndrome and cardiac ischemia to evaluate its severity and diagnosis.
This report elaborates on the market size, market characteristics, and market growth of the Cardiac Biomarkers industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Cardiac Biomarkers. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Cardiac Biomarkers Market Report Include:
Market Size Estimates: Cardiac Biomarkers market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Cardiac Biomarkers market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Cardiac Biomarkers market
Segment Market Analysis: Cardiac Biomarkers market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Cardiac Biomarkers market situations and prospects in major and top regions and countries
Cardiac Biomarkers Market
Competitive Landscape
and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.Cardiac Biomarkers Industry Chain: Cardiac Biomarkers market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Cardiac Biomarkers Industry News, Policies by regions
Cardiac Biomarkers Industry Porters Five Forces Analysis
Key players in the global Cardiac Biomarkers market are covered in Chapter 2:
Thermo Fisher Scientific Inc.
Randox laboratories Ltd.
Guangzhou Wondfo Biotech Co., Ltd
AgPlus Diagnostics
Alere Inc.
Danaher Corporation
Abbott Laboratories
LSI Medience Corporation
BioLegend
BG Medicine
Bio-Rad Laboratories
Tosoh Corporation
Siemens Healthineers AG
DiaSorin S.p.A.
Advanced ImmunoChemical
bioMérieux SA
Ortho Clinical Diagnostics
Roche Diagnostics Ltd.
In Chapter 6 and Chapter 9, on the basis of types, the Cardiac Biomarkers market from 2018 to 2028 is primarily split into:
Troponin
CK-MB
Natriuretic Peptides - BNP and NT-proBNP
Myoglobin
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Cardiac Biomarkers market from 2018 to 2028 covers:
Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Cardiac Biomarkers market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Cardiac Biomarkers industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Cardiac Biomarkers market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Cardiac Biomarkers industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Cardiac Biomarkers market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Cardiac Biomarkers market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Cardiac Biomarkers market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
